China Pharma Holdings, Inc.CPHINYSE
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank59
3Y CAGR-7.7%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-7.7%/yr
Quarterly compound
Percentile
P59
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 31.44% |
| Q2 2025 | 36.05% |
| Q1 2025 | -144.42% |
| Q4 2024 | 89.29% |
| Q3 2024 | 53.62% |
| Q2 2024 | -286.28% |
| Q1 2024 | -266.39% |
| Q4 2023 | 66.05% |
| Q3 2023 | -59.00% |
| Q2 2023 | -182.43% |
| Q1 2023 | 316.86% |
| Q4 2022 | 130.98% |
| Q3 2022 | 39.94% |
| Q2 2022 | -35.36% |
| Q1 2022 | -156.12% |
| Q4 2021 | 201.87% |
| Q3 2021 | -517.46% |
| Q2 2021 | -73.97% |
| Q1 2021 | -51.43% |
| Q4 2020 | 1089.66% |
| Q3 2020 | -95.90% |
| Q2 2020 | 491.34% |
| Q1 2020 | -32.80% |
| Q4 2019 | -22.38% |
| Q3 2019 | 127.92% |
| Q2 2019 | -75.09% |
| Q1 2019 | 484.21% |
| Q4 2018 | -133.34% |
| Q3 2018 | -11.55% |
| Q2 2018 | -45.01% |
| Q1 2018 | 54.77% |
| Q4 2017 | 61.50% |
| Q3 2017 | -34.98% |
| Q2 2017 | -9.68% |
| Q1 2017 | -58.88% |
| Q4 2016 | 398.80% |
| Q3 2016 | -27.41% |
| Q2 2016 | -24.77% |
| Q1 2016 | 360.16% |
| Q4 2015 | -56.75% |